GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Senores Pharmaceuticals Ltd
Senores Pharmaceuticals Appoints Ms. Anjali Shah as Assistant Vice President - Finance
MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 27 Jul 2026, 03:39 PM IST  ·  BSE ID: e19abb48-91b4-47e1-8cb3-6888db6c0d26
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has hired a new finance leader and shared its latest financial performance results with the public.
🤖 AI Summary
  • Ms. Anjali Shah appointed Assistant Vice President - Finance effective July 27, 2026.
  • Company disclosed unaudited financial results for the quarter ended June 30, 2026.
  • Statutory auditors issued limited review reports on the financial results.
  • Board meeting held on July 27, 2026, approved these items.
🏢 How This Affects the Company
💰
Financial Impact
The approval of unaudited financial results provides current performance data for investors and stakeholders.
⚙️
Operational Impact
The appointment of Ms. Anjali Shah as Assistant Vice President - Finance strengthens the company's senior management in its finance department.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this appointment or financial results disclosure.
👤
Who Is Affected
All shareholders are affected by the transparency provided through the financial results and management changes.
🔍
Management Signal
The appointment signals a focus on strengthening financial oversight and operational management.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Full audited financial results for FY27.
Any further updates on finance department leadership.
Performance metrics reported in subsequent financial disclosures.
LOW RISK Standard management appointment and routine financial disclosure.
💡 Investor Takeaway
Senores Pharmaceuticals appointed Ms. Anjali Shah as AVP-Finance and disclosed unaudited financial results for Q1 FY27, with auditor review reports attached.
⚖️ Strengths & Concerns

✅ Positives

  • Strengthened finance leadership team with the appointment of Ms. Anjali Shah.
  • Timely disclosure of unaudited financial results and auditor review for transparency.
❓ Frequently Asked Questions
Who has Senores Pharmaceuticals appointed as Assistant Vice President - Finance?
Senores Pharmaceuticals has appointed Ms. Anjali Shah as Assistant Vice President - Finance.
When is the appointment of Ms. Anjali Shah effective for Senores Pharmaceuticals?
The appointment of Ms. Anjali Shah is effective from July 27, 2026.
What financial results did Senores Pharmaceuticals disclose?
Senores Pharmaceuticals disclosed unaudited consolidated and standalone financial results for the quarter ended June 30, 2026.
Who provided the review report for Senores Pharmaceuticals' Q1 FY27 financial results?
M/s. Pankaj R. Shah and Associates, Chartered Accountants, provided the limited review reports on the unaudited financial results.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.